Letter to our shareholders
Fresenius set the strategic course and is moving towards #FutureFresenius with a simplified structure, sharper focus and acceleration of performance.Read more
Fresenius is at the heart of healthcare. The well-being of our patients guides our actions. This applies to sustainability at all levels.Read more
Strategy and management
Driving sustainability forward and thus creating a solid basis for future challenges is a joint task of the entire Fresenius Group.
Well-being of the patient
As a healthcare group, the safety and well-being of our patients is our top priority.
At Fresenius, we create conditions for a diverse, inclusive and equal working environment in which employees can integrate well.
The commitment of our more than 300,000 employees worldwide is the foundation of our success.
Financial Highlights FY/22
Despite a difficult macroeconomic environment, Fresenius met its FY 2022 [revised] Group sales and earnings targets.To Group financial figures
€ 37,520 m
FY/21: €37,520 m
€ -504 m
FY/21: € -504 m
€ 4,252 m
FY/21: €4,252 m
Dec. 31, 2021: 316,078
€ 1.867 m
FY/21: €1,867 m
Earnings per share2
1 In constant currency
2 Before special items
3 Net income attributable to shareholders of Fresenius SE & Co. KGaA
Fresenius is at the heart of healthcare. The focus here is on our services for patients, our clinical decisions, our drugs, our medical devices and technologies – and, above all, our patient care. Every day, our employees improve the quality of life for millions of people around the world.To the management report
In line with its new progressive dividend policy, the Company aims to increase the dividend in line with constant currency earnings per share growth but at least maintain the dividend at the prior-year’s level.
With our interactive tool you can analyze and graph a variety of key figures of the Fresenius Group and the business segments on an annual and quarterly basis.